Lilly will supply up to 600,000 doses of bebtelovimab to U.S. government in ongoing effort to…
Eli Lilly and Company announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least $720 million. The U.S. government…
Read More...
Read More...
